MedTrace Logo

Comparing the Ongoing Pregnancy Rate for Vitrification of Day-4 Morula With Day-5 Blast

NCT03787901 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2022-06-14

No results posted yet for this study

Summary

Comparing the vitrification at Day-4 (morula stage) with the blastocyst stage vitrification outcomes with the transfer of all day 5 after warming seems need evaluation. To the best of our knowledge, there has been no random-controlled trial conducted such comparison. Altogether, this trial is to evaluate the morula stage vitrification to blastocyst vitrification on the ongoing pregnancy rate after ICSI.

Conditions

Interventions

OTHER

Morula Vitrification

Evaluating the ongoing pregnancy rate following Morula vitrification compared with Blastocyst Vitrification.

Sponsors & Collaborators

  • Al Hayat ICSI Centre of Alexandria, Egypt

    collaborator UNKNOWN

  • Agial IVF/ICSI Unit of Alexandria, Egypt

    collaborator UNKNOWN

  • Al Madina Fertility centre of Alexandria, Egypt

    collaborator UNKNOWN

  • Rahem Fertility Center of Zagazig, Egypt

    collaborator UNKNOWN

  • Egyptian Foundation of Reproductive Endocrinology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-05-31
Completion
2020-06-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03787901 on ClinicalTrials.gov